Laboratorios Farmaceuticos Rovi (ES:ROVI) has released an update.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Laboratorios Farmacéuticos Rovi, S.A. has reported its operations on own shares for the second quarter of 2024, indicating active trading under its liquidity contract with Bestinver SV, S.A. The company concluded the quarter with a final balance of 92,369 shares and a cash account balance of nearly 6 million euros, reflecting a dynamic market performance.
For further insights into ES:ROVI stock, check out TipRanks’ Stock Analysis page.